C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
11/2006
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	CN1285591C Dimeric compounds and their use as anti-viral agents
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/16/2006	WO2006121922A1 Monoamine re-uptake inhibitors and methods relating thereto
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	US20060258784 New compounds, a process for their preparation and their use as dyes and pigments
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	CN1863530A (3,4-phenyl)piperidin-3-yl- phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
11/15/2006	CN1861597A Internal ester monomer compound and its application in preparing anti cancer medicine
11/14/2006	CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006	WO2005120503A3 N-aryl piperidine compounds for inhibiting hiv infection
11/09/2006	US20060252911 adamantyl diglycidyl ether or 1-adamantanol epichlorohydrin adduct curable to polyepoxides; encapsulant for light-emitting diode; superior optical properties, heat resistance, photostability, and shrinkage inhibition
11/09/2006	US20060252820 Composition for oral administration containing alkylene dioxybenzene derivative
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060251742 CO2 extraction techniques provide reduced levels of methysticin and dihydromethysticin with increased levels of kavain and dihydrokavain; paste, powder, liquid, or rapid-dissolve tablet; enhances efficacy of a botanical extract co-ingredient
11/09/2006	US20060251715 Oral delivery of a botanical
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1718640A1 Novel crystalline forms of conazoles and methods of making and using the same
11/08/2006	EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006	EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006	CN1860112A 3-amino chroman and 2-amino tetralin derivatives
11/08/2006	CN1283630C 3-substituted piperazine triadimenol antifungal compounds and their salts
11/07/2006	CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006	WO2006116355A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	WO2006116150A1 Dihydrobenzofuran derivatives and uses thereof
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006113981A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	US20060247445 dehydrating 2,3,3',4'-biphenyltetracarboxylic acid in an inert gas atmosphere under heating at 180 to 195 degrees C.; suitable for production of a polyimide
11/02/2006	US20060247439 Mchir antagonists
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	CA2605603A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	CA2604916A1 Dihydrobenzofuran derivatives and uses thereof
11/01/2006	CN1856488A Carbamoyl-type benzofuran derivatives
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006	US7129355 Process for preparing kifunensine intermediate and kifunensine therefrom
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/26/2006	WO2006113458A1 Heterocyclic inhibitors of protein arginine methyl transferases
10/26/2006	WO2006111858A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/26/2006	WO2006036941A3 Specific kinase inhibitors
10/26/2006	US20060241171 Novel physiologically active substances
10/26/2006	US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1089998B1 Epothilone derivatives and their synthesis and use
10/25/2006	CN1852892A Method for the production of bisepoxides and dithiols
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/19/2006	WO2006110884A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
10/19/2006	WO2006109084A1 Dna-pk inhibitors
10/19/2006	WO2006109081A1 Dna-pk inhibitors
10/19/2006	WO2006108711A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
10/19/2006	WO2006108487A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
10/19/2006	US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/19/2006	US20060235002 Novel physiologically active substance
10/19/2006	CA2604895A1 (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer
10/19/2006	CA2603637A1 Dna-pk inhibitors
10/19/2006	CA2598207A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
10/18/2006	EP1712642A1 Method of examining sensitivity of cancer cell to anticancer agent
10/18/2006	EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2006	EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006	CN1280290C Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
10/17/2006	US7122687 Sodium salt formation of Mycophenolic acid
10/17/2006	US7122686 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
10/17/2006	US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/12/2006	WO2006025070A3 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
10/12/2006	US20060229359 Tocopherol-modified therapeutic drug compounds
10/11/2006	EP1710244A1 Method of stabilizing macrolide compound
10/11/2006	EP1709964A2 A method of cosmetic depigmentation care by applying at least one aurone
10/11/2006	EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
10/11/2006	EP1709012A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	CN1279034C Dna－pk抑制剂 Dna-pk inhibitors
10/10/2006	US7119209 Process for preparing indolinone derivatives
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/10/2006	CA2298398C Baccatin derivatives and a process for producing the same
10/10/2006	CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
10/05/2006	WO2006105222A2 Carboxamide inhibitors of tgfb
10/05/2006	WO2006104461A1 Naphthalamide derivatives having antiproliferative activity
10/05/2006	WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives
10/05/2006	WO2006058012A3 Gonadotropin releasing hormone receptor antagonists
10/05/2006	WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006	CA2603126A1 Spirocyclic heterocyclic derivatives and methods of their use
10/04/2006	EP1515966A4 Hydroxy pyranone derivative and preparation method thereof
10/04/2006	CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B

1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 120